N@N

Synovis Life Technologies to Host Fiscal Fourth-Quarter and Full-Year Earnings Conference Call and Webcast Wednesday, Dec. 1

^{Published on 2010-11-17 13:25:36 - Market Wire}
 

ST. PAUL, Minn.--([ BUSINESS WIRE ])--Synovis Life Technologies, Inc., (NASDAQ: SYNO) will host a live conference call and webcast of its fiscal fourth-quarter and full-year on Wednesday, Dec. 1, 2010, at 10 a.m. CT. Synovis President and Chief Executive Officer Richard Kramp and Chief Financial Officer Brett Reynolds will discuss the companya™s results for the fiscal fourth quarter and full year ended Oct. 31, 2010. The company will issue a pre-market earnings news release on Wednesday, Dec. 1, 2010.

To participate in the conference call, please dial (888) 713-4217 and enter passcode 41404167. Please dial in at least 10 minutes prior to the call. Participants may pre-register for the call by logging on to the following website: [ https://www.theconferencingservice.com/prereg/key.process?key=PXDHATXFP ]. When joining the call, pre-registered participants can entire their PIN code and other participants can wait for operator assistance.

To access the live webcast, go to the investor information section of the companya™s website, [ www.synovislife.com ], on the day of the conference call and click on the webcast icon. A webcast replay will be available beginning at noon CT that day.

If you have any difficulty accessing the call or webcast, please contact Nick Banovetz of investor relations at (612) 455-1705 or [ nbanovetz@psbpr.com ].

If you do not have access to the Internet and want to listen to an audio replay of the conference call, dial (888) 286-8010 and enter access number 90191528. The audio replay will be available beginning at 2 p.m. CT on Wednesday, Dec. 1, 2010, through 6 p.m. CT on Wednesday, Dec. 8, 2010.

Synovis Life Technologies, Inc., a diversified medical device company based in St. Paul, Minn., develops, manufactures and markets mechanical and biological products used by several surgical specialties to facilitate the repair and reconstruction of soft tissue damaged or destroyed by disease or injury. The company's products include implantable biomaterials for soft tissue repair, devices for microsurgery and surgical tools a" all designed to reduce risks and/or facilitate critical surgeries, improve patient outcomes and reduce healthcare costs. For additional information on Synovis Life Technologies and its products, visit the companya™s website at [ www.synovislife.com ].